DLB insider ownership: who sold, why, and what they still hold

What stands out

Routine activity: 87% of sales were under disclosed plans, and no insider sold more than 1% of vested holdings.

A share of stake is shown for 0 of the 9 officers and directors who sold. 15 are left out

Left out: Kevin Yeaman, John Couling, David Dolby, Shriram Revankar, Robert Park, Avadis Tevanian, Mark Sherman, Simon Segars, Peter Gotcher, Todd Pendleton, Ryan Nicholson, Tony Prophet, Anjali Sud, Emily Rollins and Marc Whitten (share of stake is being verified).

Disclosed company stock is not an insider's whole wealth.

Who sold, and how much of their stake

Officers and directors, past 12 months. Their share of stake is being verified and is not shown yet; amounts and trading plans are below.

Kevin Yeaman

President and CEO, Director

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$7.0MDisclosed plan

John Couling

SVP, Entertainment

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$4.3M80% planned 20% no plan disclosed

Mark Sherman

EVP, Gen. Counsel & Secretary

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$1.1MDisclosed plan

Shriram Revankar

SVP, Advanced Technology Group

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$748KDisclosed plan

Todd Pendleton

SVP, Chief Marketing Officer

Not confirmed

Share of stake not shown: share of stake is being verified. Why

$648KNo plan disclosed

All 9 sellers

Selling by month

Officers and directors, Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planNo plan disclosedOne dollar scale for every month; the tallest bar is labeled

Recent activity

Past 30 days, Sep 17, 2026 to Oct 16, 2026

Oct 1, 2026John Couling sold 7.7K shares ($451K) under a disclosed trading plan. 7.7K shares came in from vesting or option exercises the same day, so the holding rose by 0 net.

Who	Shares	Price	% of total stake	Total stake after	Trade date	Filed
John Couling SVP, Entertainment	7,667	$58.78	n/a	n/a	Oct 1, 2026	Oct 5, 2026

"% of total stake" is the shares in an event against all the vested shares the person held that day, across every share class and holding entity, after that day's vesting. "n/a" means the person's holdings are not confirmed, or the row is a purchase. "Holdings record incomplete" means more shares were sold than the filings show the person held that day, so a percentage would be wrong.

Outside holders, reported separately

Dagmar Dolby reported no open-market sales in the past 12 months. Large shareholders and the funds or companies that board members represent are not part of management, so they are left out of the figures above.

Details

Common questions

Is the Dolby Laboratories, Inc. CEO selling stock?

Yes. Kevin Yeaman sold 105K shares ($7.0M) in the past 12 months, all of it under a trading plan disclosed in the filings.

Why are Dolby Laboratories, Inc. insiders selling?

Filings rarely give a reason, and we don't guess at one. What they show is how the sales were made: 87% of sales by value ran under 10b5-1 trading plans disclosed in the filings and 13% had no disclosed plan. A trading plan schedules sales in advance.

Are any Dolby Laboratories, Inc. insiders buying?

No. Officers and directors reported no purchases in the past 12 months.

The evidence

Who sold9 officers and directors: amount, % of holdings, trading plan

Who sold	Amount	% of holdings	Trading plan
Kevin Yeaman President and CEO, Director	$7.0M 105K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
John Couling SVP, Entertainment	$4.3M 71K shares	Not confirmed share of stake is being verified. Why	80% under a disclosed plan 20% no plan disclosed
Mark Sherman EVP, Gen. Counsel & Secretary	$1.1M 16K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Shriram Revankar SVP, Advanced Technology Group	$748K 12K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Todd Pendleton SVP, Chief Marketing Officer	$648K 12K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Ryan Nicholson VP, CAO and Corp. Controller	$360K 5.6K shares	Not confirmed share of stake is being verified. Why	No plan disclosed
Robert Park SVP & Chief Financial Officer	$277K 4.9K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Tony Prophet Director	$224K 3.3K shares	Not confirmed share of stake is being verified. Why	Disclosed plan
Emily Rollins Director	$60K 1K shares	Not confirmed share of stake is being verified. Why	Disclosed plan

Outside holder, reported separately: Dagmar Dolby (a 10% owner, not part of management). No open-market sales reported in the period. Latest filing

The full ownership picture0 of 15 officers and directors confirmed

Vested shares across all share classes, held directly and through trusts, LLCs and family members, as reported on SEC Forms 3, 4 and 5. Unvested awards and options are never counted as owned shares.

Insider

Held Oct 16, 2025

Sold

Held Oct 16, 2026

Still held

Kevin Yeaman

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. Sales and other transactions for Kevin Yeaman are complete.

President and CEO, Director

n/a

−105K

n/a

Vesting, gifts, unvested awards and holding lines for Kevin Yeaman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Kevin Yeaman are complete; balances and unit counts will be added when the check is finished.

−16Kgifted (net of own trusts)

−34Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
81,884	$87.49	Dec 15, 2033	$0
81,884	$87.49	Dec 15, 2033	$0
95,671	$77.91	Dec 16, 2034	$0
95,671	$77.91	Dec 16, 2034	$0
145,252	$66.62	Dec 15, 2035	$0
145,252	$66.62	Dec 15, 2035	$0
81,884	$87.49	Dec 15, 2033	$0
95,671	$77.91	Dec 16, 2034	$0
145,252	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

John Couling

SVP, Entertainment

n/a

−71K

n/a

Vesting, gifts, unvested awards and holding lines for John Couling

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for John Couling are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−11Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
30,327	$87.49	Dec 15, 2033	$0
36,446	$77.91	Dec 16, 2034	$0
56,440	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

David Dolby

Director

n/a

Vesting, gifts, unvested awards and holding lines for David Dolby

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for David Dolby are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Shriram Revankar

SVP, Advanced Technology Group

n/a

−12K

n/a

Vesting, gifts, unvested awards and holding lines for Shriram Revankar

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Shriram Revankar are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−12Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
28,305	$87.49	Dec 15, 2033	$0
31,890	$77.91	Dec 16, 2034	$0
49,800	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Robert Park

Holdings and share of stake are being verified. Share-of-stake figures and holdings for this company are held back while they are verified. See the filing Sales and other transactions for Robert Park are complete.

SVP & Chief Financial Officer

n/a

−4.9K

n/a

Vesting, gifts, unvested awards and holding lines for Robert Park

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Robert Park are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−8.8Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
26,283	$87.49	Dec 15, 2033	$0
31,890	$77.91	Dec 16, 2034	$0
51,460	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Avadis Tevanian

Director

n/a

Vesting, gifts, unvested awards and holding lines for Avadis Tevanian

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Avadis Tevanian are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Mark Sherman

EVP, Gen. Counsel & Secretary

n/a

−16K

n/a

Vesting, gifts, unvested awards and holding lines for Mark Sherman

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Mark Sherman are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−12Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
16,000	$62.32	Dec 15, 2027	$0
29,316	$87.49	Dec 15, 2033	$0
35,307	$77.91	Dec 16, 2034	$0
56,440	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Simon Segars

Director

n/a

Vesting, gifts, unvested awards and holding lines for Simon Segars

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Simon Segars are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Peter Gotcher

Director

n/a

Vesting, gifts, unvested awards and holding lines for Peter Gotcher

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Peter Gotcher are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Todd Pendleton

SVP, Chief Marketing Officer

n/a

−12K

n/a

Vesting, gifts, unvested awards and holding lines for Todd Pendleton

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Todd Pendleton are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−8Kwithheld by the company for taxes

Stock options (not counted as shares):

Options held	Strike price	Expires	Intrinsic value (estimate)
13,358	$71.07	Dec 15, 2032	$0
24,262	$87.49	Dec 15, 2033	$0
27,334	$77.91	Dec 16, 2034	$0
41,500	$66.62	Dec 15, 2035	$0

Estimate: options held × ($59.33 − strike price), using the most recent insider trade price on Form 4 (Oct 1, 2026), not a market close.

Ryan Nicholson

VP, CAO and Corp. Controller

n/a

−5.6K

n/a

Vesting, gifts, unvested awards and holding lines for Ryan Nicholson

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Ryan Nicholson are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

−2.2Kwithheld by the company for taxes

Tony Prophet

Director

n/a

−3.3K

n/a

Vesting, gifts, unvested awards and holding lines for Tony Prophet

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Tony Prophet are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Anjali Sud

Director

n/a

Vesting, gifts, unvested awards and holding lines for Anjali Sud

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Anjali Sud are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Emily Rollins

Director

n/a

−1K

n/a

Vesting, gifts, unvested awards and holding lines for Emily Rollins

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Emily Rollins are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Marc Whitten

President and CEO, Director

n/a

Vesting, gifts, unvested awards and holding lines for Marc Whitten

Holdings and share of stake are being verified. Sales, proceeds, plan and tax status and dates for Marc Whitten are complete; balances and unit counts will be added when the check is finished.

0gifted (net of own trusts)

Holdings and share of stake for Dolby Laboratories, Inc. are being verified, so no balances, unit counts or percentages are shown. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings.

What explains the selling$14.7M of sales by plan status, purpose, seller and month

Officer and director open-market sales: $14.7M across 230,101 shares. Plan status and stated purpose are separate questions, and a sale can have both.

By plan status

Disclosed plan · $12.8M · 87%

13%

The lighter segment is sales with no plan disclosed in the filing ($1.8M), including tax-related sales outside a plan.

No plan disclosed · $1.8M

Sales with no 10b5-1 plan and no tax reference in the filing. $840K of it is John Couling. No plan disclosed is a statement about the filing, not about why the sale happened. Largest such sale: Todd Pendleton, May 22, 2026

Taxes

87,164 shares ($5.8M) were withheld by the company for taxes, which isn't a market sale.

Charitable gifts · 16K shares

Gifts the filings describe as charitable. Gifts are not sales and are not included in the sale totals.

Seller	Shares sold	Proceeds	Under a disclosed plan	Share of total	Sales dates
Kevin Yeaman President and CEO, Director	105K	$7.0M	100%	48%	Nov 24, 2025 to Dec 17, 2025
John Couling SVP, Entertainment	71K	$4.3M	80%	29%	Nov 20, 2025 to Oct 1, 2026
Mark Sherman EVP, Gen. Counsel & Secretary	16K	$1.1M	100%	7%	Dec 1, 2025 to Dec 17, 2025
Shriram Revankar SVP, Advanced Technology Group	12K	$748K	100%	5%	Nov 21, 2025 to Aug 14, 2026
Todd Pendleton SVP, Chief Marketing Officer	12K	$648K	0%	4%	May 22, 2026 to May 22, 2026
Ryan Nicholson VP, CAO and Corp. Controller	5.6K	$360K	0%	2%	Feb 13, 2026 to Aug 25, 2026
Robert Park SVP & Chief Financial Officer	4.9K	$277K	100%	2%	May 12, 2026 to May 12, 2026
Tony Prophet Director	3.3K	$224K	100%	2%	Nov 25, 2025 to Nov 25, 2025
Emily Rollins Director	1K	$60K	100%	0.4%	Apr 1, 2026 to Apr 1, 2026

Sales by month

Month	Sale proceeds	Disclosed plan	To cover taxes	No plan disclosed
Oct 2025	$0	$0	$0	$0
Nov 2025	$3.3M	$2.9M	$0	$408K
Dec 2025	$6.1M	$6.1M	$0	$0
Jan 2026	$0	$0	$0	$0
Feb 2026	$808K	$198K	$0	$610K
Mar 2026	$0	$0	$0	$0
Apr 2026	$60K	$60K	$0	$0
May 2026	$1.8M	$1.2M	$0	$648K
Jun 2026	$426K	$426K	$0	$0
Jul 2026	$408K	$408K	$0	$0
Aug 2026	$831K	$648K	$0	$182K
Sep 2026	$468K	$468K	$0	$0
Oct 2026	$451K	$451K	$0	$0

Is this normal? Selling year by year5 earlier years to compare with

Less than usual: about half of the 5-year average. 9 insiders sold; the average is 8 a year.

12 months ending	Shares sold	Insiders who sold	Proceeds
Oct 16, 2026 Latest 12 months	230K	9	$14.7M
Oct 16, 2025 1 year earlier	409K	8	$31.7M
Oct 16, 2024 2 years earlier	223K	5	$18.2M
Oct 17, 2023 3 years earlier	411K	10	$34.6M
Oct 17, 2022 4 years earlier	236K	6	$19.1M
Oct 17, 2021 5 years earlier	1.01M	10	$92.7M

Open-market sales (Form 4 code S) by people who were officers or directors, in split-adjusted shares. Earlier years include people who have since left. A sale that an outside holder also reports (a family trust, a fund) is counted with outside holders in every year. Shares, not dollars, are compared, so a change in the stock price doesn't look like a change in selling. Years the filings don't fully cover are shown but left out of the average.

Known gaps and uncertainty15 officers and directors not confirmed

Holdings and share of stake are being verified. Balances, unit counts and every share-of-stake figure for Dolby Laboratories, Inc. are held back until that check is finished. Sales, proceeds, plan and tax status, titles and dates come straight from individual filings and are complete.

External context: we only cite outside events when a documented connection exists. None is shown for this period.

Sources and methodology1,710 filings on record, 47 filed in the 12-month period, and how we read them

All 1,710 Forms 3, 4 and 5 on record for Dolby Laboratories, Inc. (SEC CIK 1308547), filed from Feb 15, 2005 to Oct 5, 2026; 47 of them were filed in the 12 months this page covers, retrieved from SEC EDGAR on Oct 16, 2026. Prices are the ones reported in each filing, often weighted averages.

Holdings. Each holding line (a share class plus an owner, such as a trust or LLC) carries its last reported balance forward. Entities first reported during the period start at zero, so transfers between an insider's own trusts don't count as selling. Lines not reported for three years or more are listed separately and left out of totals.

Sales. A sale counts as under a 10b5-1 plan if its footnote cites one or the filing's Rule 10b5-1 box is checked, and as tax-related if its footnote cites tax obligations or sell-to-cover. Shares withheld by the company for taxes are listed separately. Sales with neither attribute are labeled "no plan disclosed".

Full methodology

Former or inactive filers (24)No filing in 18 months; last reported balances, not in any total

Name	Last filed	Last reported balance
Micheline Chau	Feb 9, 2023	66,882 shares, last reported balance as of Feb 7, 2023
Roger Siboni	Feb 9, 2022	37,554 shares, last reported balance as of Feb 8, 2022
Steven Forshay	Dec 23, 2021	55,805 shares, last reported balance as of Dec 15, 2021
Lewis Chew	Aug 18, 2021	105,598 shares, last reported balance as of Aug 17, 2021
William Jasper Jr.	Feb 4, 2021	15,627 shares, last reported balance as of Feb 2, 2021
Giles Baker	Dec 23, 2020	32,376 shares, last reported balance as of Dec 23, 2020
Dagmar Dolby 2019 Trust BB,dated July 22, 2019	Oct 1, 2019	3,700,000 shares, last reported balance as of Aug 2, 2019
Dagmar Dolby 2018 Trust BB, Dated June 20, 2018	Feb 27, 2019	3,800,000 shares, last reported balance as of Feb 22, 2019
Nicholas Donatiello Jr.	May 17, 2018	22,331 shares, last reported balance as of May 17, 2018
Bob Borchers	Dec 19, 2017	45,032 shares, last reported balance as of Dec 15, 2017
Michael Bergeron	Aug 18, 2016	47,496 shares, last reported balance as of Aug 16, 2016
Michael Rockwell	Jan 27, 2015	99,697 shares, last reported balance as of Jan 26, 2015
Sanford Robertson	Aug 1, 2014	24,325 shares, last reported balance as of Jul 31, 2014
Ray Dolby	Jun 11, 2013	142,827,478 shares, last reported balance as of Jun 10, 2013
Ramzi Haidamus	Mar 20, 2013	113,477 shares, last reported balance as of Mar 19, 2013
Murray Demo	May 29, 2012	24,960 shares, last reported balance as of May 25, 2012
Ted Hall	Feb 9, 2012	34,538 shares, last reported balance as of Feb 7, 2012
Mark Anderson	Dec 17, 2010	18,900 shares, last reported balance as of Dec 16, 2010
Michael Novelly	Apr 6, 2009	7,800 shares, last reported balance as of Mar 28, 2009
Timothy Partridge	Mar 5, 2009	23,349 shares, last reported balance as of Mar 3, 2009
Martin Jaffe	Feb 24, 2009	15,463 shares, last reported balance as of Feb 23, 2009
David Watts	Nov 16, 2006	33,000 shares, last reported balance as of Nov 14, 2006
Eduard Schummer	Feb 2, 2006	68,201 shares, last reported balance as of Feb 1, 2006
Janet Daly	Jun 21, 2005	59,255 shares, last reported balance as of Feb 16, 2005

Spotted something wrong on this page? Report an error. We check every report against the SEC filing and list what we fix in the corrections log.

Dolby Laboratories, Inc. insiders sold $14.7M in the past 12 months. How much of their stake is that?

What stands out

Who sold, and how much of their stake

Selling by month

Recent activity

Outside holders, reported separately

Common questions

Is the Dolby Laboratories, Inc. CEO selling stock?

Why are Dolby Laboratories, Inc. insiders selling?

Are any Dolby Laboratories, Inc. insiders buying?

The evidence

No plan disclosed · $1.8M

Taxes

Charitable gifts · 16K shares

Sales by month